EUVIMEDEUVIMED entdecken
Fallbericht

Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/Ivacaftor

Julie Park, Anna Walsh, Sue Kerr, Clare Woodland, Suzanne Southward, Mark Deakin, Senthil Senniappan, Rebecca Thursfield

Hormone Research in Paediatrics · 2024

DOI: 10.1159/000530571 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Julie Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Alder Hey Children's Hospital, Liverpool, UK. Hauptthemen laut MEDLINE: Cystic Fibrosis, Diabetes Mellitus, Hypoglycemia, Benzodioxoles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are increasingly used in children and young people with cystic fibrosis (CF). Data in adults show there may be an impact on glycaemic control in those with CF-related diabetes (CFRD). Paediatric data are rare. Case Series/Presentation: Children aged >12 years with CFRD, who were eligible for elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) were commenced on treatment. Glucose monitoring via the FreeStyle Libre system was commenced prior to, immediately after, and several months after commencing ELX/TEZ/IVA. Glycaemic control, shown by time in range (3–10 mmol/L), percentage of time spent hypoglycaemic (<3 mmol/L), and percentage of time spent hyperglycaemic (>10 mmol/L) on Insulin doses were recorded. Following ELX/TEZ/IVA, four of seven children stopped insulin, two required substantially reduced doses of insulin, one showed no response. Glycaemic control remained similar on lower doses or no insulin. Hypoglycaemia was detected in those not requiring insulin.

Conclusion

ELX/TEZ/IVA has a positive impact on glycaemic control and insulin requirements in children with CFRD. Close monitoring is required when commencing treatment. Children with CFRD need counselling regarding possible reductions in insulin requirement and re-education regarding symptoms, signs, and management of hypoglycaemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisDiabetes MellitusHypoglycemiaBenzodioxolesIndolesAminophenolsPyrazolesPyridinesPyrrolidinesQuinolonesAdultHumansChildAdolescentGlucoseBlood Glucose Self-MonitoringBlood GlucoseInsulinMutation

Stichwörter der Autor:innen

Cystic fibrosisCystic fibrosis transmembrane receptor modulatorsDiabetes in children and adolescentsGlucoseGlycaemic control

Substanzen

GlucoseelexacaftorivacaftortezacaftorBlood GlucoseInsulinBenzodioxolesIndolesAminophenolsPyrazoles

Autor:innen und Institutionen

  • Department of Endocrinology, Alder Hey Children's Hospital, Liverpool, UK.
  • University of Liverpool, Liverpool, UK.
  • Department of Diabetes, Alder Hey Children's Hospital, Liverpool, UK.
  • Department of Respiratory, Alder Hey Children's Hospital, Liverpool, UK.
  • Leighton Hospital, Crewe, UK.

Zitieren

APA

Park, J., Walsh, A., Kerr, S., Woodland, C., Southward, S., Deakin, M., Senniappan, S., & Thursfield, R. (2024). Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/Ivacaftor. Hormone Research in Paediatrics. https://doi.org/10.1159/000530571

Vancouver

Park J, Walsh A, Kerr S, Woodland C, Southward S, Deakin M, et al. Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/Ivacaftor. Hormone Research in Paediatrics. 2024. doi:10.1159/000530571

BibTeX
@article{Park2024,
  author = {Park, Julie and Walsh, Anna and Kerr, Sue and Woodland, Clare and Southward, Suzanne and Deakin, Mark and Senniappan, Senthil and Thursfield, Rebecca},
  title = {Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/Ivacaftor},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  doi = {10.1159/000530571}
}
Kostenlos starten →